JBIO ▲ +0.8% - Jade Biosciences, Inc.
$JBIO reported Q3 2026 EPS of -$0.42, beating the -$0.78 estimate by 46.2%. Revenue was $0. No analyst estimate was published for revenue
13-NOV-2026 07:10 AM ET
Share this post
More filings for $JBIO
JBIO ▲ +0.8% - Jade Biosciences, Inc.Nov 13, 2026JBIO ▲ +0.2% - Jade Biosciences, Inc.Nov 3, 2026JBIO - Jade Biosciences, Inc. - SEC Filing Update (28-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 28, 2026JBIO - Jade Biosciences, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026JBIO ▼ -0.1% - Jade Biosciences, Inc.Oct 21, 2026JBIO ▼ -0.0% - Jade Biosciences, Inc.Sep 1, 2026
View full $JBIO filing history →💬 Comments
Loading comments…
Leave a comment